Announcements Trials

Browse Landscape

Phase

Status

Terminated 1 Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Carcinoma, Transitional Cell 3 Urinary Bladder Neoplasms 2 Urologic Neoplasms 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Non-Muscle Invasive Bladder Neoplasms 1 Neoplasms 1 Carcinoma in Situ 1

Interventions

Gemcitabine 34 pembrolizumab 27 Paclitaxel 21 Cyclophosphamide 21 Docetaxel 20 Carboplatin 20 Irinotecan 19 Capecitabine 19 Fluorouracil 17 Bevacizumab 15 Dexamethasone 14 fludarabine 13 Oxaliplatin 13 Leucovorin 13 Blood Specimen Collection 13 Everolimus 12 Cetuximab 12 Ipilimumab 11 Erlotinib Hydrochloride 11 Rituximab 10 Pemetrexed 10 Cisplatin 10 venetoclax 9 Temozolomide 9 Sunitinib 9 Nivolumab 9 Trastuzumab 8 Interleukin-2 8 aldesleukin 7 Epoetin Alfa 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Neoplasms × enfortumab vedotin × Clear all

NCT05097599 2025-01-08

StrataPATH

Strata Oncology

Phase 2 Terminated

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡